Nanoparticle platform can deliver siRNA across blood–brain barrier in mouse model of TBI
Researchers from Brigham and Women’s Hospital and Boston Children’s Hospital (both MA, USA) have created a nanoparticle packaging system that can facilitate transport of therapeutics into the brains of mice. The breakthrough could herald a potential new avenue for treatment of traumatic brain injury (TBI), as therapeutics can be delivered regardless of the state of the blood–brain barrier (BBB). Findings published in Science Advances have demonstrated the new technique in a mouse model of TBI. Physicians have long faced challenges when treating patients after TBI, as there is a limited window of time in which the BBB is breached, allowing...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!